Omer Mirza, MD

NPI 1780046532ActiveIndividual· Internal Medicine, Critical Care Medicine· Dallas, TX

Internal Medicine, Critical Care Medicine (MD) in Dallas, Texas, trained at University of Texas Medical School at San Antonio (class of 2016). Their prescriptions cost Medicare Part D more than their services did: $260,618 for 240 claims, against $96,470 paid for services in 2024. Merck Sharp & Dohme LLC reported $27.11 in payments in 2025, mostly food and beverage.

Overview

NPI	1780046532
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	Yes
NPI issued	Mar 22, 2016
Last updated in NPPES	Apr 21, 2026
Certified by provider	Apr 21, 2026

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Critical Care Medicine Primary	207RC0200X	S1866	TX
Internal Medicine, Pulmonary Disease	207RP1001X	S1866	TX
Hospitalist	208M00000X	S1866	TX

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	315
Services billed	812 across 44 procedure codes
Paid by Medicare	$96,470

Part D prescriptions in 2024

Prescriptions (claims)	240 · 322 30-day fills
Patients	57
Total drug cost	$260,618
Generic share	37% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Medical School at San Antonio
Graduation year	2016
Medicare specialty	Pulmonary Disease
Secondary specialties	Critical Care (Intensivists), Internal Medicine